PFPT
VRTX icon

Pinnacle Financial Partners (Tennessee)’s Vertex Pharmaceuticals VRTX Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3.81M Buy
9,719
+102
+1% +$42.6K 0.09% 177
2025
Q2 		$4.28M Buy
9,617
+263
+3% +$121K 0.09% 182
2025
Q1 		$4.53M Buy
9,354
+3,158
+51% +$1.47M 0.09% 176
2024
Q4 		$2.5M Sell
6,196
-445
-7% -$206K 0.05% 209
2024
Q3 		$3.09M Buy
6,641
+6,029
+985% +$2.9M 0.06% 192
2024
Q2 		$287K Buy
612
+20
+3% +$8.68K 0.01% 376
2024
Q1 		$247K Sell
592
-50
-8% -$21.1K 0.01% 399
2023
Q4 		$261K Buy
+642
New +$237K 0.01% 376
2023
Q3 		– Sell
-600
Closed -$211K – 568
2023
Q2 		$211K Buy
+600
New +$202K 0.01% 381
2022
Q1 		– Sell
-1,039
Closed -$229K – 484
2021
Q4 		$229K Buy
+1,039
New +$202K 0.01% 367
2021
Q2 		– Sell
-933
Closed -$200K – 482
2021
Q1 		$200K Sell
933
-84
-8% -$18.4K 0.01% 339
2020
Q4 		$240K Sell
1,017
-304
-23% -$69.8K 0.01% 325
2020
Q3 		$360K Buy
1,321
+6
+0.5% +$1.66K 0.02% 268
2020
Q2 		$382K Buy
+1,315
New +$357K 0.02% 256

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s VRTX Position: Q3 2025 in Review

Pinnacle Financial Partners (Tennessee) increased its Vertex Pharmaceuticals (VRTX) stake by 1.1% in Q3 2025, buying an estimated $42.6K and bringing the position to 9,719 shares worth $3.81M. The position accounts for 0.09% of the portfolio, ranked #177.

Pinnacle Financial Partners (Tennessee) first reported a position in VRTX in Q2 2020 and has held it in 14 quarters since. The position peaked at $4.53M in Q1 2025. 1,519 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • Pinnacle Financial Partners (Tennessee) held 9,719 shares of Vertex Pharmaceuticals worth $3.81M as of Q3 2025.
  • Pinnacle Financial Partners (Tennessee) bought 102 Vertex Pharmaceuticals shares in Q3 2025, an estimated $42.6K.
  • Vertex Pharmaceuticals made up 0.09% of Pinnacle Financial Partners (Tennessee)'s portfolio in Q3 2025, its #177 holding.
  • Pinnacle Financial Partners (Tennessee) first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 14 quarters since.
  • Pinnacle Financial Partners (Tennessee)'s Vertex Pharmaceuticals position peaked at $4.53M in Q1 2025.
  • 1,519 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q3 2025, filed 28 Oct 2025.